Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Indian Journal of Hematology and Blood Transfusion
Literature
1.
Zhu SH, Sun JY, Bonnevie E, Cummins SE, Gamst A, Yin L et al (2014) Four hundred and sixty brands of e-cigarettes and counting: implications for product regulation. Tob Control 23(Suppl. 3):iii3–iii9CrossRef
2.
Maessen GC, Wijnhoven AM, Neijzen RL, Paulus MC, van Heel DAM, Bomers BHA, Boersma LE, Konya B, van der Heyden MAG (2019) Nicotine intoxication by e-cigarette liquids: a study of case reports and pathophysiology. Clin Toxicol (Phila) 9:1–8
3.
Kaur G, Muthumalage T, Rahman I (2018) Mechanisms of toxicity and biomarkers of flavoring and flavor enhancing chemicals in emerging tobacco and non-tobacco products. Toxicol Lett 15(288):143–155CrossRef
4.
Muthumalage T, Prinz M, Ansah KO, Gerloff J, Sundar IK, Rahman I (2018) Inflammatory and oxidative responses induced by exposure to commonly used E-cigarette flavoring chemicals and flavored e-liquids without nicotine. Front Physiol 8:1130CrossRef
5.
Khan MS, Khateeb F, Akhtar J, Khan Z, Lal A, Kholodovych V, Hammersley J (2018) Organizing pneumonia related to electronic cigarette use: a case report and review of literature. Clin Respir J 12(3):1295–1299CrossRef
6.
Morgan DL, Jokinen MP, Price HC, Gwinn WM, Palmer SM, Flake GP (2012) Bronchial and bronchiolar fibrosis in rats exposed to 2,3-pentanedione vapors: implications for bronchiolitis obliterans in humans. Toxicol Pathol 40(3):448–465CrossRef
7.
Flach S, Maniam P, Manickavasagam J (2019) E-cigarettes and head and neck cancers: a systematic review of the current literature. Clin Otolaryngol 44(5):749–756CrossRef
8.
McConnell DD, Carr SB, Litofsky NS (2019) Potential effects of nicotine on glioblastoma and chemoradiotherapy: a review. Expert Rev Neurother 19(6):545–555CrossRef
9.
10.
11.
Jankowski M, Krzystanek M, Zejda JE, Majek P, Lubanski J, Lawson JA, Brozek G (2019) E-cigarettes are more addictive than traditional cigarettes—a study in highly educated young people. Int J Environ Res Public Health 16(13):2279CrossRef
12.
Sahu KK, Badhala P, Malhotra P, Aggarwal AN (2016) A rare case of rituximab induced interstitial lung disease. Lung India 33(4):472–473CrossRef
13.
Sahu KK, Varma SC (2015) Herpes zoster complicating bortezomib therapy. Indian J Med Res 141(2):247–248CrossRef
Metadata
Title
From Oncologist’s Desk: Hemato-Oncological Aspect of Using Vaporizers, E-Cigarettes, and Other Electronic Nicotine Delivery Systems (ENDS)
Authors
Kamal Kant Sahu
Ajay Kumar Mishra
Amos Lal
Ahmad Daniyal Siddiqui
George M. Abraham
Publication date
01-01-2020
Publisher
Springer India
Published in
Indian Journal of Hematology and Blood Transfusion / Issue 1/2020
Print ISSN: 0971-4502
Electronic ISSN: 0974-0449
DOI
https://doi.org/10.1007/s12288-019-01177-8

Other articles of this Issue 1/2020

Indian Journal of Hematology and Blood Transfusion 1/2020 Go to the issue

Correspondence

Priapism in Childhood B-Cell Acute Lymphoblastic Leukemia: A Rare Presentation

Short Communication

Marburg I Polymorphism (G511E) in Adults with Deep Vein Thrombosis

Images

Dysplastic Erythroblastic Islands in Paroxysmal Nocturnal Hemoglobinuria (PNH)

Original Article

Phenotypic Diversity and Clinico-Hematological Profile of Hb E-Beta Thalassemic Children

Correspondence

An Unusual Case of Fungating Chest Wall Mass

Original Article

TET2 Single Nucleotide Polymorphism in Myeloid Neoplasms Among Egyptian Patients
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits